IAI. I. Almazova

I. I. Almazova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. I. Almazova has a total of 197 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanisms of brain aging. A review: Part I

    by S. A. Berns, A. V. Veremeev, I. M. Lobachev, A. V. Shirshov, E. A. Korshikova, Yu. S. Timofeev, I. R. Gilmutdinova, I. I. Almazova, O. M. Drapkina, С. А. Бернс, et al.

    This review examines current concepts of brain aging as a complex, multifactorial process affecting the structural, functional, and molecular levels of nervous tissue. Particular attention is paid to age-related changes in neurons and synapses, impaired protein synthesis, the role of oxidative stress and chronic inflammation, as well as compensatory neurophysiological mechanisms that maintain cognitive functions despite involutional processes. The review discusses the impact of changes in neurotransmitter systems, reduced regenerative capacity of stem cells, and the contribution of lifestyle factors to the rate of aging. Following key pathogenetic mechanisms corresponding to modern "hallmarks of aging" are highlighted: genomic instability and DNA damage, epigenetic alterations, telomere attrition, impaired proteostasis and autophagy, mitochondrial dysfunction, cellular senescence of neurons and glia, reduced regenerative potential of neural stem cells, as well as vascular and cardiac remodeling. It is shown that these processes form an interconnected cascade leading to cognitive decline and an increased risk of neurodegenerative diseases. Understanding these processes opens perspectives for developing strategies for early diagnosis and comprehensive preventive interventions targeting both neurobiological and cardiovascular components of aging.

  • Open Access

    Prostate cancer screening of specific adult population groups. Guidelines

    by O. M. Drapkina, A. D. Kaprin, S. A. Ivanov, L. Yu. Drozdova, B. Ya. Alekseev, R. N. Shepel, Zh. V. Khailova, N. V. Vorobiev, I. I. Almazova, N. A. Rubtsova, et al.

    These guidelines contain information on the theoretical foundations of prostate cancer screening, regulatory acts governing the management of prostate cancer screening of specific adult population groups, the specifics of interpreting the results of laboratory and imaging examinations during prostate cancer screening, and patient routing algorithms. These guidelines have been developed for the heads of health facilities providing primary healthcare, including primary care physicians, general practitioners, urologists, and specialists with secondary medical education who are directly involved in outpatient screening of specific adult population groups.

  • Lung cancer screening as a part of the preventive medical examination of certain groups of the adult population. Methodological recommendations

    by O.M. Drapkina, I.S. Stilidi, A.D. Kaprin, A.M. Belyaev, K.K. Laktionov, I.E. Tyurin, S.A. Ivanov, V.E. Sinitsyn, I.I. Almazova, N.A. Rubtsova, et al.

    The guidelines contain information on the theoretical foundations of lung cancer screening, regulatory legal acts regulating the organization of lung cancer screening events in the framework of medical examinations of certain groups of the adult population, the technological process of low-dose computed tomography screening, and the specifics of forming conclusions based on the results of computed tomography of the chest organs. The guidelines have been developed for the heads of medical organizations providing primary health care in terms of organizing processes, radiologists, internists, general practitioners, and medical professionals from among the secondary medical staff who are directly involved in the implementation of the medical examination process for certain groups of the adult population. The guidelines were approved at a meeting of the Scientific Council of the Federal State Budgetary Institution «NMIC TPM» of the Ministry of Health of the Russian Federation (Protocol No. 7 dated 09/16/2025).

  • Open Access

    The main provisions of the guidelines of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia on the population-based colorectal cancer screening

    by O. M. Drapkina, A. D. Kaprin, Yu. A. Shelygin, S. I. Achkasov, L. Yu. Drozdova, R. N. Shepel, R. R. Abdrakhmanov, S. V. Kashin, D. V. Zavyalov, M. E. Zharova, et al.

    Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths both globally and in Russia. Screening is a key element in the prevention and early diagnosis of CRC. This guide presents current guidelines aimed at managing effective CRC screening among the adult population as part of routine health examinations. The primary goal of screening is to identify precancerous conditions and early stages of CRC for timely treatment and an improved prognosis. The guidelines include a list of target groups, particularly individuals aged 40 to 75 years, as well as individuals with a family history or other risk factors. The key screening method is a immunochemical fecal occult blood test, followed by a colonoscopy in positive results. Particular attention is paid to compliance with standards for the preparation and conduct of examinations. The guidelines outline the stages of patient care, from initial identification to specialized treatment, including regulatory frameworks and the use of information systems for monitoring and reporting outcomes. These guidelines are rested on evidence-based medicine and are an essential tool for primary care specialists and healthcare executives.


  • Open Access

    The main provisions of the guidelines of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia on the population-based colorectal cancer screening

    by O. M. Drapkina, A. D. Kaprin, Yu. A. Shelygin, S. I. Achkasov, L. Yu. Drozdova, R. N. Shepel, R. R. Abdrakhmanov, S. V. Kashin, D. V. Zavyalov, M. E. Zharova, et al.

    Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths both globally and in Russia. Screening is a key element in the prevention and early diagnosis of CRC. This guide presents current guidelines aimed at managing effective CRC screening among the adult population as part of routine health examinations.The primary goal of screening is to identify precancerous conditions and early stages of CRC for timely treatment and an improved prognosis. The guidelines include a list of target groups, particularly individuals aged 40 to 75 years, as well as individuals with a family history or other risk factors.The key screening method is a immunochemical fecal occult blood test, followed by a colonoscopy in positive results. Particular attention is paid to compliance with standards for the preparation and conduct of examinations.The guidelines outline the stages of patient care, from initial identification to specialized treatment, including regulatory frameworks and the use of information systems for monitoring and reporting outcomes.These guidelines are rested on evidence-based medicine and are an essential tool for primary care specialists and healthcare executives.

  • Open Access

    Screening of malignant neoplasms of the breast as part of the medical examination of certain groups of the adult population. Guidelines

    by O. M. Drapkina, A. D. Kaprin, I. I. Almazova, L. Yu. Drozdova, E. S. Ivanova, N. I. Rozhkova, N. A. Rubtsova, J. V. Khailova, R. N. Shepel, Ж. В. Хайлова

    The Guidelines contain information on the theoretical foundations of screening for malignant neoplasms of the breast, regulatory legal acts regulating the organization of screening activities within the framework of medical examination of certain groups of the adult population, diagnostic algorithms and routing of the examined persons. Guidelines have been developed for the heads of medical organizations providing primary health care in terms of organizing processes, internists, general practitioners, medical workers from among the secondary medical personnel who are directly involved in the implementation of the process of medical examination of certain groups of the adult population.


  • Open Access

    Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines

    by O. M. Drapkina, A. V. Kontsevaya, A. M. Kalinina, S. N. Avdeev, M. V. Agaltsov, L. I. Alekseeva, I. I. Almazova, E. Yu. Andreenko, D. N. Antipushina, Yu. A. Balanova, et al.

    Создание руководства поддержано Советом по терапевтическим наукам отделения клинической медицины Российской академии наук.


  • Open Access

    “STRING OF BEADS” IN A PATIENT WITH RENOVASCULAR HYPERTENSION (CLINICAL CASE)

    by Алена Алексеевна Савичева, Светлана Александровна Бернс, Ильда Исмаиловна Алмазова, Irina V. Kuznetsova, Денис Нарендрович Кхатри, Борис Александрович Руденко, Maria V. Kuznetsova, Оксана Михайловна Драпкина, Мария Витальевна Кузнецова

    HighlightsFibromuscular dysplasia (FMD) is an idiopathic, non-atherosclerotic muscular layer artery lesion predominantly affecting the carotid and renal arteries. This pathology is quite rare in the general population and is most often diagnosed in women. In this article, on the example of a clinical case, up-to-date information is presented regarding the features of the clinical picture, diagnostic and therapeutic algorithms in patients with FMD, which may be useful for physicians of different specialties. AbstractArterial hypertension in young people is most common cause of another disease. The task of the physician who encounters such a patient is to make up a specific plan for further action.Despite the low fibromuscular dysplasia incidence in the population, this disease is relevant for differential diagnosis in young patients with arterial hypertension. The presented clinical case clearly shows that a timely diagnosis and timely treatment can help to prevent the development of complications and improve the patient's quality of life.


  • Open Access

    Cerebrovascular Accident in a Patient with Polycythemia: a Case Report

    by O. M. Drapkina, I. I. Almazova, A. V. Smirnova, S. A. Berns, R. N. Shepel

    Polycythemia vera is not only a clonal disease that causes hematopoietic stem cells, but also a pathology that often leads to thrombotic complications. Thrombosis can have different localization and is clinically manifested by stroke, myocardial infarction, deep vein thrombosis of the lower extremities, pulmonary embolism, thrombosis of the veins of internal organs and other conditions. One of the most formidable thrombotic complications is acute cerebrovascular accident. The heterogeneity of the possible causes of acute cerebrovascular accident requires a careful approach to differential diagnosis for timely diagnosis and individual, pathogenetically grounded selection of means of long-term antithrombotic therapy. The presented clinical case of the development of cerebrovascular accident in a patient with polycythemia vera demonstrates the importance of an informal approach to diagnosis, as well as interdisciplinary interaction for finding the true cause of the development of acute cerebrovascular accident and the appointment of pathogenetically based treatment, aimed, among other things, at the prevention of repeated episodes of acute cerebrovascular accident and others. thrombotic complications.


  • Open Access

    Hypertension as a mask of ANCA-associated glomerulonephritis

    by V. S. Bashnyak, E. M. Mamutova, S. A. Berns, I. I. Almazova, N. V. Shashkova, R. N. Shepel, O. M. Drapkina

    Glomerulonephritis associated with antineutrophil cytoplasmic antibodies (ANCA) is one of the causes of renal parenchymal disease, which can lead to secondary hypertension (HTN). Clinical course of HTN in this case is usually mild, however, high blood pressure can become the only reason to refer to a primary care physician. We report a case of a 45-year old woman with renal parenchymal disease due to ANCA-glomerulonephritis and secondary HTN. HTN was the only clinical manifestation of the disease led to the hospital admission. With this clinical case we emphasize that primary care physicians should always attempt to identify secondary causes of HTN.